AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- Do you know that the seasonal influenza market has grown rapidly in recent years?
Projections show that the seasonal influenza market will expand from $8.41 billion in 2024 to $9.88 billion in 2025, showcasing a compound annual growth rate CAGR of 17.4%. The previous growth phase can be attributed to factors such as the increasing prevalence of influenza, a rising elderly population, and the escalation in the prevalence of infectious and chronic diseases. Additionally, there has been a growing burden of influenza-related illness and a rise in respiratory infections.
What are the future projections of the seasonal influenza market size?
In the next few years, the seasonal influenza market size is expected to witness substantial growth. It is projected to grow to $18.55 billion in 2029-- a growth propelled by a compound annual growth rate CAGR of 17.1%. The expected growth during this period can be attributed to the rising demand for oral drug solutions, expanding R&D activities, increasing vaccination counts, an improving healthcare infrastructure, and growing demand in retail pharmacies.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp
What's pushing such rapid growth?
A closer look reveals that significant trends in the forecast period include advanced treatment procedures, technological advancements, vaccine technological progress, mRNA technology, and digital health solutions for monitoring and diagnosis. There is also a clear thrust on the increasing prevalence of respiratory infections which are expected to propel the market. These infections, caused by viruses or bacteria, affect the respiratory system, including the sinuses, throat, airways, or lungs. The rising prevalence is driven by factors such as air pollution, changing climates, weakened immune responses, and the ease of viral transmission in crowded or poorly ventilated spaces.
Which companies are leading the charge in the seasonal influenza market?
Key industry players currently operating in the market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., and several others.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report
In terms of new trends, major companies operating in the seasonal influenza market are focusing on advancements in treatment. These include combination vaccines that enhance immunity by targeting multiple strains of the virus, thereby improving effectiveness and reducing the need for frequent vaccinations.
How does the seasonal influenza market break down?
This report shares the market segmentation into four key areas - Type, Route Of Administration, Distribution Channel, and Treatment. Further, these segments are broken down into detailed subsections to provide a comprehensive understanding of the market.
Finally, let's take a look at the geographical breakdown. North America was the largest region in the seasonal influenza market in 2024. However, expectations are high for Asia-Pacific to be the fastest-growing region in the forecast period. The report covers an in-depth analysis of various geographical regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse For More Similar Reports-
Influenza Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report
Influenza Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report
Virus Filtration Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/virus-filtration-global-market-report
To conclude, understanding the seasonal influenza market's nuanced dynamics can offer substantial benefits. Don't miss out on valuable insights and opportunities. The Business Research Company, with over 15000+ reports from 27 industries covering 60+ geographies, is known for offering comprehensive, data-rich research and insights. Stay ahead in the game with our unique insights from industry leaders.
For more such discerning data, get in touch with us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
